Gynostemma pentaphyllum for dyslipidemia: A systematic review of randomized controlled trials.
- 2022-08-26
- Systematic Review
- Frontiers in pharmacology 13
- Ning Dai
- Fang-Fang Zhao
- Min Fang
- Feng-Lan Pu
- Ling-Yao Kong
- Jian-Ping Liu
- PubMed: 36091752
- DOI: 10.3389/fphar.2022.917521
- High evidence
- Clinical
GP plus n-3 fatty acid was superior in normalization of triglycerides (TG) and total cholesterol (TC) than n-3 fatty acids (RR 1.34, 95% CI 1.01-1.77).
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes